Dextromethorphan and guaifenesin use should be monitored diligently in sufferers with "very poor metabolizer" CYP2D6 enzyme degrees and patients who are sedated. This mix medication has a big median poisonous dose (TD50) to median helpful dose (ED50) ratio (or therapeutic index) in these individuals. 资助维基百科 外观 创建账号 登录 个人工具 创建账号 https://a-pvp-kaufen04680.blogmazing.com/29602537/dextromethorphan-dxm-for-sale-in-europe-secrets